High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma
✍ Scribed by Maisnar, V; Hájek, R; Ščudla, V; Gregora, E; Büchler, T; Tichý, M; Kotouček, P; Kafková, A; Forraiová, L; Minařík, J
- Book ID
- 110015506
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 136 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Multiple lymphomatous polyposis (mlp) results from gastrointestinal involvement by a b-cell lymphoma that originates from the mantle zone of lymphoid follicles. this well described clinicopathologic entity has a poor prognosis: the rate of complete response after conventional chemoth
## Abstract High‐dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a standard therapy for newly diagnosed multiple myeloma. Combinations of recently proposed prognostic factors such as cytogenetics and international scoring system (ISS) may be useful to predict prognosis